Charles River Laboratories Total Long-Term Assets 2010-2024 | CRL

Charles River Laboratories total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Charles River Laboratories total long-term assets for the quarter ending June 30, 2024 were $6.449B, a 2.89% increase year-over-year.
  • Charles River Laboratories total long-term assets for 2023 were $6.586B, a 6.86% increase from 2022.
  • Charles River Laboratories total long-term assets for 2022 were $6.164B, a 7.19% increase from 2021.
  • Charles River Laboratories total long-term assets for 2021 were $5.75B, a 34.05% increase from 2020.
Charles River Laboratories Annual Total Long-Term Assets
(Millions of US $)
2023 $6,586
2022 $6,164
2021 $5,750
2020 $4,290
2019 $3,671
2018 $2,958
2017 $2,103
2016 $2,055
2015 $1,509
2014 $1,291
2013 $1,080
2012 $1,101
2011 $1,132
2010 $1,180
2009 $1,608
Charles River Laboratories Quarterly Total Long-Term Assets
(Millions of US $)
2024-06-30 $6,449
2024-03-31 $6,485
2023-12-31 $6,586
2023-09-30 $6,163
2023-06-30 $6,268
2023-03-31 $6,251
2022-12-31 $6,164
2022-09-30 $5,967
2022-06-30 $6,136
2022-03-31 $5,742
2021-12-31 $5,750
2021-09-30 $5,679
2021-06-30 $5,452
2021-03-31 $4,386
2020-12-31 $4,290
2020-09-30 $4,073
2020-06-30 $4,006
2020-03-31 $3,994
2019-12-31 $3,671
2019-09-30 $3,610
2019-06-30 $3,615
2019-03-31 $3,060
2018-12-31 $2,958
2018-09-30 $2,958
2018-06-30 $2,976
2018-03-31 $2,158
2017-12-31 $2,103
2017-09-30 $2,084
2017-06-30 $2,036
2017-03-31 $1,997
2016-12-31 $2,055
2016-09-30 $2,036
2016-06-30 $2,061
2016-03-31 $1,466
2015-12-31 $1,509
2015-09-30 $1,454
2015-06-30 $1,256
2015-03-31 $1,233
2014-12-31 $1,291
2014-09-30 $1,236
2014-06-30 $1,271
2014-03-31 $1,061
2013-12-31 $1,080
2013-09-30 $1,096
2013-06-30 $1,102
2013-03-31 $1,111
2012-12-31 $1,101
2012-09-30 $1,110
2012-06-30 $1,095
2012-03-31 $1,118
2011-12-31 $1,132
2011-09-30 $1,129
2011-06-30 $1,157
2011-03-31 $1,184
2010-12-31 $1,180
2010-09-30 $1,553
2010-06-30 $1,549
2010-03-31 $1,573
2009-12-31 $1,608
2009-09-30 $1,625
2009-06-30 $1,584
2009-03-31 $1,506
Sector Industry Market Cap Revenue
Medical Medical Services $11.285B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00